Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules By Ludvig M. Sollid, Shuo-Wang Qiao, Robert P. Anderson, Carmen Gianfrani, Frits Koning Published in: Immunogenetics DOI: 10.1007/s00251-012-0599-z ABSTRACT Celiac disease is caused by an abnormal intestinal T-cell response to gluten proteins of wheat, barley and rye. Over the last few years, a number of gluten T-cell epitopes restricted by celiac disease associated HLA-DQ molecules have been characterized. In this work, we give an overview of these epitopes and suggest a comprehensive, new nomenclature. Celiac disease (CD) is caused by an abnormal intestinal immune response to proline and glutamine-rich wheat gluten proteins and to similar proteins in barley and rye (Green and Cellier 2007). Oat is generally considered safe for consumption by CD patients (Garsed and Scott 2007), although some patients appear to be sensitive to oat as well (Lundin et al. 2003). The only established treatment for the disease is a lifelong gluten exclusion diet. CD has a strong HLA association. The most prominent association is with HLA-DQ2.5 (DQA1*05:01, DQB1*02:01) (Table 1). In individuals who carry the DR3DQ2 haplotype, this molecule is encoded by DQA1 and DQB1 alleles located on the same chromosome (in cis configuration), whereas in individuals who are DR5DQ7/DR7DQ2 heterozygous it is encoded by alleles located on opposite chromosomes (trans configuration) (Sollid et al. 1989). Most of the remaining patients carry DR4DQ8 haplotypes, and in these patients it is the DQ8 molecule encoded by DQA1*03, DQB1*03:02 that is involved in the pathogenesis (Lundin et al. 1994). In the small remaining population of CD patients that are neither DQ2.5 or DQ8, the patients typically express HLA-DQ molecules that contain ‘half’ of DQ2.5 molecule as they are either DQ2.2 (DQA1*02:01, DQB1*02:01) or DQ7.5 (DQA1*05, DQB1*03:01) (Karell et al. 2003). As both the DQA1 and DQB1 loci are polymorphic, unique HLA-DQ molecules can be encoded in trans configuration. Examples of such molecules are DQ2.3 (DQA1*03, DQB1*02:01) and DQ8.5 (DQA1*05, DQB1*03:02) found in DR3DQ2/DR4DQ8 heterozygous individuals (Table 1).Table 1Description and naming of HLA-DQ molecules that are associated with celiac disease and which are used as antigen presenting elements for CD4+ T cells of celiac disease patientsEncoded byRisk for celiac diseaseExpression in cis or trans positionPart of common cis haplotypeHLA-DQ moleculeDQA1*DQB1*HLA-DQ2.50502High cis, trans DR3DQ2HLA-DQ2.20202Low cis, (trans) DR7DQ2HLA-DQ2.30302Likely lowa trans, (cis) b HLA-DQ7.50503:01Very low cis, (trans) DR5DQ7HLA-DQ80303:02Low cis DR4DQ8HLA-DQ8.50503:02Likely lowa trans, (cis) b aRisk for celiac disease has not been established in population studies bMolecule can also be encoded in cis on some rare haplotypes CD4+ T cells of CD patients (Lundin et al. 1993), but not healthy subjects (Molberg et al. 1997), recognize gluten peptides when presented by disease associated HLA-DQ molecules. This was first shown for DQ2.5 and DQ8 (Lundin et al. 1994), and recently it was demonstrated that DQ2.2 patients (Bodd et al. 2012) and a patient who carries DQ8.5 in a rare cis configuration (Kooy-Winkelaar et al. 2011) also have gluten-reactive T cells in the intestinal mucosa. Gluten-reactive T cells can readily be established from intestinal biopsies cultured in vitro (Camarca et al. 2009; Lundin et al. 1993, 1994; Tye-Din et al. 2010; Vader et al. 2002b; van de Wal et al. 1998b). T cells recognizing the same gluten epitopes are normally not detected in the peripheral blood (Anderson et al. 2000), but can be found in the blood of treated CD patients on day 6 after a 3-day oral gluten challenge (Anderson et al. 2000, 2005; Ráki et al. 2007). HLA is the most important genetic factor in CD, and carriage of certain HLA alleles is a necessary, but not sufficient, factor for disease development (Sollid 2002). The other factors required for disease development are non-HLA genes, of which 39 loci have been identified so far (Trynka et al. 2011), and possibly environmental factors other than gluten. To note, mice transgenic for HLA-DQ2.5 and gluten specific T-cell receptors do not develop a CD-like enteropathy (de Kauwe et al. 2009; Du Pre et al. 2011). The reason why these mice do not develop enteropathy may relate to fundamental differences in the gut physiology between mouse and man, and to the lack of appropriate non-MHC genes in the mouse strains tested that parallel the non-HLA susceptibility genes of CD patients. The differential risk of DQ2.5 and DQ2.2 is linked with the T-cell response to gluten. It has been demonstrated that DQ2.5 binds a larger gluten peptide repertoire compared to DQ2.2 (Vader et al. 2003b). Further, gluten T-cell epitopes form stable complexes with DQ2.5, and the increased risk of DQ2.5 over DQ2.2 correlates with a different ability of the two HLA molecules to form stable complexes with many gluten peptides (Fallang et al. 2009). Characteristically, gluten-reactive T cells of CD patients recognize their antigenic peptides much better when specific glutamine residues are converted to glutamate by the enzyme transglutaminase 2 (TG2) (Molberg et al. 1998; van de Wal et al. 1998a). Deamidated gluten peptides bind with increased affinity to DQ2.5 and DQ8 (Arentz-Hansen et al. 2000; Camarca et al. 2009; Henderson et al. 2007; Kim et al. 2004; Moustakas et al. 2000; Quarsten et al. 1999), and the rate of dissociation of deamidated gluten peptides from DQ2.5 has been shown to be substantially slower than for their native counterparts (Xia et al. 2005). The ability to form stable peptide–MHC complexes again seems to be a key factor for the initiation of the anti-gluten T-cell response. Gluten is defined as the cohesive mass that remains when dough is washed to remove starch (Shewry et al. 1992). Traditionally and strictly speaking, gluten is a name of wheat proteins only, but gluten is now increasingly used as a term to denote proline- and glutamine-rich proteins of wheat, barley, rye and oat. In wheat, gluten consists of the gliadin and glutenin subcomponents. The gliadin proteins can be subdivided into α-, γ- and ω-gliadins, while the glutenin proteins can be subdivided into high molecular weight (HMW) and low molecular weight (LMW) subunits. Common bread wheat is a hexaploid species, and in addition some of the gluten protein encoding genes originate from duplicated loci. Thus, in a single wheat variety there exits up to several hundred different gluten proteins, many of which only differ by a few amino acids. The proline- and glutamine-rich proteins of barley, rye and oat are termed hordeins, secalins and avenins, respectively. Given the heterogeneity of the wheat gluten proteins, it is no surprise that many distinct gliadin and glutenin derived T-cell epitopes exist (Table 2). T-cell epitopes derived from either α-, γ-, and ω-gliadins as well as from HMW and LMW glutenins have been reported (Arentz-Hansen et al. 2000; Sjöström et al. 1998; Vader et al. 2002b; van de Wal et al. 1998b). T-cell epitopes in both hordeins and secalins have been described and they are highly homologous to those found in wheat (Tye-Din et al. 2010; Vader et al. 2003a). The avenins of oat are more distinct, and although oat is considered safe for CD patients (Garsed and Scott 2007), some CD patients are clinically sensitive to oat (Lundin et al. 2003). Avenin specific as well as cross-reactive responses have been described (Arentz-Hansen et al. 2004; Vader et al. 2003a).Table 2List of celiac disease relevant T-cell epitopes recognized by CD4+ T cellsEpitopea Previous namesPeptide-binding registerb Reference123456789DQ2.5 restricted epitopesDQ2.5-glia-α1aDQ2-α-I, α9PFPQP E LPY(Arentz-Hansen et al. 2000)DQ2.5-glia-α1bDQ2-α-IIIPYPQP E LPY(Arentz-Hansen et al. 2002)DQ2.5-glia-α2DQ2-α-II, α2PQP E LPYPQ(Arentz-Hansen et al. 2000)DQ2.5-glia-α3glia-α20FRP E QPYPQ(Vader et al. 2002b)DQ2.5-glia-γ1DQ2-γ-IPQQSFP E Q Q (Sjöström et al. 1998)DQ2.5-glia-γ2DQ2-γ-II, γ30IQP E QPAQL(Qiao et al. 2005; Vader et al. 2002b)DQ2.5-glia-γ3DQ2-γ-III Q QP E QPYP Q (Arentz-Hansen et al. 2002)DQ2.5-glia-γ4aDQ2-γ-IVSQP E Q E FPQ(Arentz-Hansen et al. 2002)DQ2.5-glia-γ4bDQ2-γ-VIIcPQP E Q E FPQ(Qiao et al. 2005)DQ2.5-glia-γ4cDQ2-γ-VIIa Q QP E QPFPQ(Arentz-Hansen et al. 2002)DQ2.5-glia-γ4dDQ2-γ-VIIbPQP E QPFC Q (Qiao, unpublished)DQ2.5-glia-γ5DQ2-γ-VIQQPFP E QPQ(Arentz-Hansen et al. 2002)DQ2.5-glia-ω1DQ2-ω-IPFPQP E QPF(Tye-Din et al. 2010)DQ2.5-glia-ω2DQ2-ω-IIPQP E QPFPW(Tye-Din et al. 2010)DQ2.5-glut-L1glutenin-17PFS E Q E QPV(Vader et al. 2002b)DQ2.5-glut-L2glutenin-156FS Q QQ E SPF(Stepniak et al. 2005; Vader et al. 2002b)DQ2.5-hor-1Hor-α9, Hα9PFPQP E QPF(Tye-Din et al. 2010; Vader et al. 2003a)DQ2.5-hor-2Hor-α2, Hα2PQP E QPFPQ(Vader et al. 2003a)DQ2.5-hor-3hor-I-DQ2PIP E QPQPY(Tye-Din et al. 2010)DQ2.5-sec-1Sec-α9, Sα9PFPQP E QPF(Tye-Din et al. 2010; Vader et al. 2003a)DQ2.5-sec-2Sec-α2, Sα2PQP E QPFPQ(Vader et al. 2003a)DQ2.5-ave-1aAv-α9APYPEQ E EPF(Arentz-Hansen et al. 2004; Vader et al. 2003a)DQ2.5-ave-1bAv-α9B, 1490PYPEQ E QPF(Arentz-Hansen et al. 2004; Vader et al. 2003a)DQ2.2 restricted epitopesDQ2.2-glut-L1glutenin-17PFS E Q E QPV(Bodd et al. 2012)DQ8 restricted epitopesDQ8-glia-α1DQ8-α-I E GSFQPSQ E (van de Wal et al. 1998b)DQ8-glia-γ1aDQ8-γ-Ia E QP Q QPFPQ(Tollefsen et al. 2006)DQ8-glia-γ1bDQ8-γ-Ib E QP Q QPYP E (Tollefsen et al. 2006)DQ8-glut-H1HMW-glutenin Q GYYPTSP Q (van de Wal et al. 1999)DQ8.5 restricted epitopesDQ8.5-glia-α1DQ8-α-I E GSFQPSQ E (Kooy-Winkelaar et al. 2011)DQ8.5-glia-γ1PQQSFP E Q E (Kooy-Winkelaar et al. 2011)DQ8.5-glut-H1HMW-glutenin Q GYYPTSP Q (Kooy-Winkelaar et al. 2011) aIn the epitope names, these short terms are used to denote the type of proteins that the epitopes derive from: ‘glia-α’ denotes α-gliadin, ‘glia-γ’ denotes γ-gliadin, ‘glia-ω’ denotes ω-gliadin, ‘glut-L’ denotes low molecular weight glutenin, ‘glut-H’ denotes high molecular weight glutenin, ‘hor’ denotes hordein, ‘sec’ denotes secalin and ‘ave’ denotes avenin bGlutamate residues (E) formed by TG2-medited deamidation which are important for recognition by T cells are shown in bold. Additional glutamine residues also targeted by TG2 are underlined There is at present no standard nomenclature for CD-relevant gluten epitopes. Here, we propose such a nomenclature based on the following three criteria:Reactivity against the epitope must have been defined by at least one specific T-cell clone.The HLA-restriction element involved must have been unequivocally defined.The nine-amino acid core of the epitope must have been defined either by an analysis with truncated peptides and/or HLA-binding with lysine scan of the epitope or comparable approach. Searching the literature using these criteria, we have compiled a list of epitopes (Table 2). This list includes sequences from α-gliadin, γ-gliadin, ω-gliadin, LMW- and HMW-glutenins, hordeins, secalins and avenins. To note, most gluten-reactive T cells have minimal epitopes longer than those listed in Table 2. This is because MHC class II restricted T-cell receptors usually are sensitive to a few residues flanking the nine-amino acid core region of the epitopes. In Table 2, some sequences that previously were defined as individual epitopes have been grouped together as members of the same family. This pertains to the DQ2.5-glia-α1a and DQ2.5-glia-α1b as well as the DQ2.5-glia-γ4a, DQ2.5-glia-γ4b, DQ2.5-glia-γ4c and DQ2.5-glia-γ4d epitopes. The reason is that the sequences defining these epitopes are very similar, although there are occasionally T-cell clones that can distinguish between members of the same epitope family (Arentz-Hansen et al. 2002; Qiao et al. 2005). Most T-cell clones appear to cross-react between peptide sequences of the same family. The nine-amino acid core sequences of some of the DQ2.5 restricted epitopes are identical, but because these epitopes derive from different cereal species they are still listed as unique epitopes. This applies to the DQ2.5-glia-ω1, DQ2.5-hor-1 and DQ2.5-sec-1 epitopes, as well as DQ2.5-hor-2 and DQ2.5-sec-2 epitopes. T-cell cross-reactivity between proteins of different species hence does often occur, but T cells reactive with these epitopes can also be species-specific as the T-cell receptors may be sensitive to unique residues flanking the nine-amino acid core region of the epitopes. In addition, there are epitopes, like DQ2.5-hor-3 (Tye-Din et al. 2010), that have sequences which are hordein or secalin specific and which elicit species specific T-cell responses. The majority of gluten-reactive T cells generated from DQ2.5 positive CD patients can recognize their epitopes when confronted in vitro with antigen presenting cells expressing the closely related HLA-DQ2.2 molecule (DQA1*02:01, DQB1*02:01). Yet, DQ2.2 positive CD patients do not mount a T-cell response to the same gluten epitopes, but rather have responses to gluten peptides that bind stably to DQ2.2 (Bodd et al. 2012). When defining an epitope, it is thus important to assess and categorize the epitope only in the context of the HLA molecules that are expressed by the T-cell donor. The selection of gluten T-cell epitopes is best understood in HLA-DQ2.5 positive CD patients, and is influenced by at least three factors: (a) resistance of the polypeptide sequence to proteolytic degradation, (b) specificity of TG2 and (c) HLA binding specificity. The proline-rich nature of gluten makes the gluten proteins resistant to proteolytic degradation in the gastrointestinal lumen, and long gluten peptide fragments ranging from 15 to 50 residues therefore survive in the small intestine (Shan et al. 2002). T-cell epitopes are often localized within such long fragments (Arentz-Hansen et al. 2002). The resulting proline and glutamine rich peptides are often good substrates for TG2 (Dørum et al. 2009, 2010; Fleckenstein et al. 2002; Vader et al. 2002a). Proline is influencing the specificity of TG2 as the enzyme typically recognizes glutamine residues in glutamine-X-proline sequences (Fleckenstein et al. 2002; Vader et al. 2002a). T-cell epitopes in their native form are usually very good substrates for TG2. TG2, being an important factor in the selection of T-cell epitopes, is demonstrated by the fact that TG2 is selectively targeting peptides which harbor T-cell epitopes from a digest of gluten with extreme complexity (Dørum et al. 2010). Finally, determinant selection by MHC is influencing repertoire of T-cell epitopes. In general, gluten peptides are poor binders to HLA class II molecules with the exception of HLA-DQ molecules associated with CD (Bergseng et al. 2008). Some gluten peptides also bind HLA-DR53 (Clot et al. 1999), although so far no T cells of celiac lesions recognizing these peptides have been described. The selective force of HLA is illustrated by the observation that the DQ2.5 and DQ8 epitopes generally come from non-overlapping sequences of gluten proteins (Tollefsen et al. 2006). The glutamate introduced by TG2 is usually in position 4 (P4), P6 or P7 in HLA-DQ2.5 restricted epitopes and at position P1 and/or P9 in HLA-DQ8 restricted epitopes (Table 2). These glutamate residues serve as anchor residues important for binding of the peptides. Both HLA-DQ2.5 and DQ8 prefer negatively charged residues at these anchors sites. This positioning of deamidated glutamine residues is strongly related to the positioning of proline residues, which is particularly strict in the case of DQ2.5 epitopes, as DQ2.5 only accepts proline at certain position in the peptide binding groove (Kim et al. 2004). This results in a dominant presence of proline at P1, P6 and P8 and leads to the modification by TG2 of the glutamine residues at P4 and P6, respectively. Such positioning of proline residues is less strict in the case of the DQ8 epitopes. Although polyclonal T-cell responses to multiple T-cell epitopes are almost invariably found in CD patients, responses to the DQ2.5-glia-α1a, DQ2.5-glia-α1b, DQ2.5-glia-α2 epitopes, DQ2.5-glia-ω1, DQ2.5-glia-ω2, DQ2.5-hor-1 and DQ2-sec-1 are dominant in DQ2.5 positive patients (Arentz-Hansen et al. 2000; Camarca et al. 2009; Tollefsen et al. 2006; Tye-Din et al. 2010). In DQ8-positive patients, responses to the DQ8-glia-α1 epitope are most frequently found (Tollefsen et al. 2006; van de Wal et al. 1998b). The list of gluten epitopes recognized by T cells of CD patients presented in Table 2 will be extended as new epitopes become known in the future. A dedicated website (http://www.isscd.org/EpitopeNomenclature) will update this list as more epitopes are identified. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. ReferencesAndersonRPDeganoPGodkinAJJewellDPHillAVIn vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitopeNat Med2000633734210.1038/7320010700238AndersonRPvan HeelDATye-DinJABarnardoMSalioMJewellDPHillAVT cells in peripheral blood after gluten challenge in coeliac diseaseGut2005541217122310.1136/gut.2004.05999816099789PMC1774637Arentz-HansenHKörnerRMolbergQHVaderWKooyYMLundinKEAKoningFRoepstorffPSollidLMMcAdamSNThe intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminaseJ Exp Med200019160361210.1084/jem.191.4.60310684852PMC2195837Arentz-HansenHMcAdamSNMolbergFBLundinKEJorgensenTJJungGRoepstorffPSollidLMCeliac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residuesGastroenterology200212380380910.1053/gast.2002.3538112198706Arentz-HansenHFleckensteinBMolbergSHKoningFJungGRoepstorffPLundinKESollidLMThe molecular basis for oat intolerance in patients with celiac diseasePlos Med20041e110.1371/journal.pmed.001000115526039PMC523824BergsengESidneyJSetteASollidLMAnalysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II moleculesHum Immunol2008699410010.1016/j.humimm.2008.01.00218361933Bodd M, Kim CY, Lundin KE, Sollid LM (2012) Characterization of the T-cell reponse to gluten in patients with celiac disease expressing HLA-DQ2.2 but not any other HLA-DQ risk molecules. Gastroenterology, in press10.1053/j.gastro.2011.11.02122108197CamarcaAAndersonRPMamoneGFierroOFacchianoACostantiniSZanziDSidneyJAuricchioSSetteATronconeRGianfraniCIntestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac diseaseJ Immunol20091824158416610.4049/jimmunol.080318119299713PMC3306175ClotFGianfraniCBabronMCBouguerraFSouthwoodSKagnoffMFTronconeRPercopoSEliaouJFClerget-DarpouxFSetteAGrecoLHLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptidesImmunogenetics19994980080710.1007/s00251005055410398807de KauweALChenZAndersonRPKeechCLPriceJDWijburgOJacksonDCLadhamsJAllisonJMcCluskeyJResistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cellsJ Immunol20091827440745010.4049/jimmunol.090023319494267DørumSQiaoSWSollidLMFleckensteinBA quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac diseaseJ Proteome Res200981748175510.1021/pr800960n19239248DørumSArntzenMOQiaoSWHolmAKoehlerCJThiedeBSollidLMFleckensteinBThe preferred substrates for transglutaminase 2 in a complex wheat gluten digest are peptide fragments harboring celiac disease T-cell epitopesPLoS One20105e1405610.1371/journal.pone.001405621124911PMC2988817Du PreMFKozijnAEvan BerkelLAter BorgMNLindenbergh-KortleveDJensenLTKooy-WinkelaarYKoningFBoonLNieuwenhuisEESollidLMFuggerLSamsomJNTolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cellsGastroenterology201114161062010.1053/j.gastro.2011.04.04821683079FallangLEBergsengEHottaKBerg-LarsenAKimCYSollidLMDifferences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentationNat Immunol20091010961010110.1038/ni.178019718029FleckensteinBMolbergQSWSchmidDGVon DerMFElgstoenKJungGSollidLMGliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation processJ Biol Chem2002277341093411610.1074/jbc.M20452120012093810GarsedKScottBBCan oats be taken in a gluten-free diet? A systematic reviewScand J Gastroenterol20074217117810.1080/0036552060086394417327936GreenPHCellierCCeliac diseaseN Engl J Med20073571731174310.1056/NEJMra07160017960014HendersonKNTye-DinJAReidHHChenZBorgNABeissbarthTTathamAManneringSIPurcellAWDudekNLvan HeelDAMcCluskeyJRossjohnJAndersonRPA structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac diseaseImmunity200727233410.1016/j.immuni.2007.05.01517629515KarellKLoukaASMoodieSJAscherHClotFGrecoLCiclitiraPJSollidLMPartanenJHLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac DiseaseHum Immunol20036446947710.1016/S0198-8859(03)00027-212651074KimCYQuarstenHBergsengEKhoslaCSollidLMStructural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac diseaseProc Natl Acad Sci U S A20041014175417910.1073/pnas.030688510115020763PMC384714Kooy-WinkelaarYvan LummelMMoustakasAKSchweizerJMearinMLMulderCJRoepBODrijfhoutJWPapadopoulosGvan BergenJKoningFGluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQβ transdimerJ Immunol20111875123512910.4049/jimmunol.110117922013116LundinKEAScottHHansenTPaulsenGHalstensenTSFausaOThorsbyESollidLMGliadin-specific, HLA-DQ(α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patientsJ Exp Med199317818719610.1084/jem.178.1.1878315377PMC2191064LundinKEAScottHFausaOThorsbyESollidLMT cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8Hum Immunol19944128529110.1016/0198-8859(94)90047-77883596LundinKEANilsenEMScottHGLøbergEMGjøenABratlieJSkarVMendezELøvikAKettKOats induced villous atrophy in coeliac diseaseGut2003521149115210.1136/gut.52.11.1649PMC177385414570737MolbergOKettKScottHThorsbyESollidLMLundinKEAGliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controlsScand J Immunol19974610310910.1046/j.1365-3083.1997.d01-93.x-i29315123MolbergOMcAdamSNKörnerRQuarstenHKristiansenCMadsenLFuggerLScottHRoepstorffPLundinKEASjöströmHSollidLMTissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cellsNat Med1998471371710.1038/nm0698-7139623982MoustakasAKvan de WalYRoutsiasJKooyYMVan VeelenPDrijfhoutJWKoningFPapadopoulosGKStructure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopesInt Immunol2000121157116610.1093/intimm/12.8.115710917890QiaoSWBergsengEMolbergOJungGFleckensteinBSollidLMRefining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidationJ Immunol20051752542611597265610.4049/jimmunol.175.1.254QuarstenHMolbergFLMcAdamSNSollidLMHLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitopeEur J Immunol1999292506251410.1002/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-910458765RákiMFallangLEBrottveitMBergsengEQuarstenHLundinKESollidLMTetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patientsProc Natl Acad Sci U S A20071042831283610.1073/pnas.060861010417307878PMC1800789ShanLMolbergPIHauschFFilizFGrayGMSollidLMKhoslaCStructural basis for gluten intolerance in celiac sprueScience20022972275227910.1126/science.107412912351792ShewryPRTathamASKasardaDDMarshMNCereal proteins and coeliac diseasecoeliac disease1992OxfordBlackwell Scientific PublicationsSjöströmHLundinKEAMolbergKRMcAdamSNAnthonsenDQuarstenHNorenORoepstorffPThorsbyESollidLMIdentification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognitionScand J Immunol19984811111510.1046/j.1365-3083.1998.00397.x9716100SollidLMCoeliac disease: dissecting a complex inflammatory disorderNat Rev Immunol2002264765510.1038/nri88512209133SollidLMMarkussenGEkJGjerdeHVartdalFThorsbyEEvidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimerJ Exp Med198916934535010.1084/jem.169.1.3452909659PMC2189170StepniakDVaderLWKooyYvan VeelenPAMoustakasAPapandreouNAEliopoulosEDrijfhoutJWPapadopoulosGKKoningFT-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1Immunogenetics20055781510.1007/s00251-005-0780-815714306TollefsenSArentz-HansenHFleckensteinBMolbergRMKwokWWJungGLundinKESollidLMHLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac diseaseJ Clin Invest20061162226223610.1172/JCI2762016878175PMC1518792TrynkaGHuntKABockettNARomanosJMistryVSzperlABakkerSFBardellaMTBhaw-RosunLCastillejoGde la ConchaEGde AlmeidaRCDiasKRvan DiemenCCDuboisPCDuerrRHEdkinsSFrankeLFransenKGutierrezJHeapGAHrdlickovaBHuntSIzurietaLPIzzoVJoostenLALangfordCMazzilliMCMeinCAMidahVMitrovicMMoraBMorelliMNutlandSNunezCOnengut-GumuscuSPearceKPlatteelMPolancoIPotterSRibes-KoninckxCRicano-PonceIRichSSRybakASantiagoJLSenapatiSSoodASzajewskaHTronconeRVaradeJWallaceCWoltersVMZhernakovaAThelmaBKCukrowskaBUrcelayEBilbaoJRMearinMLBarisaniDBarrettJCPlagnolVDeloukasPWijmengaCvan HeelDADense genotyping identifies and localizes multiple common and rare variant association signals in celiac diseaseNat Genet2011431193120110.1038/ng.99822057235PMC3242065Tye-DinJAStewartJADromeyJABeissbarthTvan HeelDATathamAHendersonKManneringSIGianfraniCJewellDPHillAVMcCluskeyJRossjohnJAndersonRPComprehensive, quantitative mapping of T cell epitopes in gluten in celiac diseaseSci Transl Med2010241ra5110.1126/scitranslmed.300101220650871VaderLWde RuAvan DerWYKooyYMBenckhuijsenWMearinMLDrijfhoutJWvan VeelenPKoningFSpecificity of tissue transglutaminase explains cereal toxicity in celiac diseaseJ Exp Med200219564364910.1084/jem.2001202811877487PMC2193762VaderWKooyYvan VeelenPde RuAHarrisDBenckhuijsenWPenaSMearinLDrijfhoutJWKoningFThe gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptidesGastroenterology20021221729173710.1053/gast.2002.3360612055577VaderLWStepniakDTBunnikEMKooyYMde HaanWDrijfhoutJWvan VeelenPAKoningFCharacterization of cereal toxicity for celiac disease patients based on protein homology in grainsGastroenterology20031251105111310.1016/S0016-5085(03)01204-614517794VaderWStepniakDKooyYMearinLThompsonAvan RoodJJSpaenijLKoningFThe HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responsesProc Natl Acad Sci U S A2003100123901239510.1073/pnas.213522910014530392PMC218768van de WalYKooyYvan VeelenPPenaSMearinLPapadopoulosGKoningFSelective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivityJ Immunol1998161158515889712018van de WalYKooyYMvan VeelenPAPenaSAMearinLMMolbergLKEASollidLMMutisTBenckhuijsenWEDrijfhoutJWKoningFSmall intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadinProc Natl Acad Sci U S A199895100501005410.1073/pnas.95.17.100509707598PMC21459van de WalYKooyYMvan VeelenPVaderWAugustSADrijfhoutJWPenaSAKoningFGlutenin is involved in the gluten-driven mucosal T cell responseEur J Immunol1999293133313910.1002/(SICI)1521-4141(199910)29:10<3133::AID-IMMU3133>3.0.CO;2-G10540324XiaJSollidLMKhoslaCEquilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2Biochemistry2005444442444910.1021/bi047747c15766274